Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Yeast
LEU1
encodes the second enzyme in leucine biosynthesis. A 3.5-kilobase pair (kb) yeast genomic DNA fragment which complements a leu1 auxotroph was isolated by yeast transformation. After recloning into an integrating vector, a subfragment (of the 3.5-kb fragment) directs a URA3 marker to integrate at the
LEU1
locus. About 1.9 kb was sequenced from the 5'-end of the 3.5-kb insert, and a long open reading frame and potential ATG start codon were located.
S1 nuclease
mapping showed a major start for
LEU1
transcripts at 79 nucleotides upstream of the ATG codon. Northern blots with a
LEU1
-specific probe showed the size of the
LEU1
transcript (about 2.9 kb) is consistent with the size of the enzyme and steady state levels of the transcript are sharply reduced in cells grown in the presence of an elevated leucine concentration. The latter observation correlates with the repression by leucine of
LEU1
gene product levels. Other work has shown that the level of the LEU2 gene product is also repressed by leucine. Sequence comparisons between
LEU1
and LEU2 show that the LEU2 5'-sequences which are cognate to leucine are not found in
LEU1
; and three blocks of nucleotide sequence homology between
LEU1
and LEU2 occur in the 330 nucleotides upstream of the respective start codons.
...
PMID:Yeast LEU1. Repression of mRNA levels by leucine and relationship of 5'-noncoding region to that of LEU2. 632 36